"We are what our parents and grandparents ate, and how they lived," says Dr. Mark Hanson, Director of the Academic Unit of Human Development and Health at the University of Southhampton in the United Kingdom. This chilling but increasingly recognized prospect concerning intergenerational passsages of disease risk helped found the Developmental Origins of Health and Disease (DOHaD) study, a worldwide collaboration aimed at better understanding environmental to genetic determinants of health across multiple generations. In this discussion with host Dr. Matt Birnholz, Dr. Hanson highlights the science behind broadening our scope of individualized care to include both past and future generations of each patient.
Breaking Inter-Generational Cycles of Disease Determinism: The DOHaD Project

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
"We are what our parents and grandparents ate, and how they lived," says Dr. Mark Hanson, Director of the Academic Unit of Human Development and Health at the University of Southhampton in the United Kingdom. This chilling but increasingly recognized prospect concerning intergenerational passsages of disease risk helped found the Developmental Origins of Health and Disease (DOHaD) study, a worldwide collaboration aimed at better understanding environmental to genetic determinants of health across multiple generations. In this discussion with host Dr. Matt Birnholz, Dr. Hanson highlights the science behind broadening our scope of individualized care to include both past and future generations of each patient.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Updates From the 7th World Symposium Task Force
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
First-line Chemotherapy Options in Metastatic PDAC
Second-line Chemotherapy Options in Metastatic PDAC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?